JNJ - JOHNSON & JOHNSON
207.78
2.000 0.963%
Share volume: 2,376,541
Last Updated: 12-24-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.12%
PREVIOUS CLOSE
CHG
CHG%
$205.78
2.00
0.01%
Summary score
61%
Profitability
53%
Dept financing
39%
Liquidity
75%
Performance
71%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2013 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
5.6%
Return on assets
3.58%
Return on sales
28.52%
Return on invested capital
6.5%
Total debt ratio
51.03%
Debt ratio change over timeo
0%
Current Ratio
2.08%
Quick Ratio
1.74%
Cash Position Ratio
0.65%
Short-term ratios 30-Sep-2016 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last year.
Return on equity
5.53%
Return on assets
3.51%
Return on sales
28.11%
Return on invested capital
6.14%
Total debt ratio
51.75%
Debt ratio change over timeo
0%
Current Ratio
1.91%
Quick Ratio
1.59%
Cash Position Ratio
0.62%
Last quarter ratios 30-Sep-2017
The data are presented for the financials results of the last quarter.
Return on equity
5.09%
Return on assets
3.14%
Return on sales
24.92%
Return on invested capital
4.59%
Total debt ratio
52.47%
Debt ratio change over time
0%
Current Ratio
1.32%
Quick Ratio
1.02%
Cash Position Ratio
0.49%
Performance ratios (change over 4 years) 30-Sep-2013 - 30-Sep-2017
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | JNJ | LLY | ABBV | NVO |
|---|---|---|---|---|
| Return on equity | 5.6% | 4.12% | 28.84% | 21.75% |
| Return on assets | 3.58% | 2.87% | 3.88% | 12.86% |
| Return on sales | 28.52% | 20.56% | 38.24% | 43.62% |
| Return on invested capital | 6.5% | 4.34% | 4.27% | -154.84% |
| Profitability | 53% | 38% | 71% | 69% |
| Total debt ratio | 51.03% | 63.22% | 91.42% | 53.2% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 39% | 17% | 25% | 15% |
| Current Ratio | 1.91% | 1.35% | 1.56% | 1.25% |
| Quick Ratio | 1.59% | 0.99% | 1.42% | 0.93% |
| Cash Position Ratio | 0.62% | 0.31% | 0.55% | 0.41% |
| Liquididy | 75% | 44% | 64% | 44% |
| Short-term ratios | JNJ | LLY | ABBV | NVO |
|---|---|---|---|---|
| Return on equity | 5.53% | 3.9% | 29.97% | 21.28% |
| Return on assets | 3.51% | 2.93% | 3.83% | 12.59% |
| Return on sales | 28.11% | 20.94% | 37.61% | 43.44% |
| Return on invested capital | 6.14% | 4.21% | 4.25% | -151.68% |
| Profitability | 53% | 38% | 72% | 68% |
| Total debt ratio | 51.75% | 64.39% | 91.67% | 53.34% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 39% | 18% | 25% | 15% |
| Current Ratio | 1.91% | 1.35% | 1.56% | 1.25% |
| Quick Ratio | 1.59% | 0.99% | 1.42% | 0.93% |
| Cash Position Ratio | 0.62% | 0.31% | 0.55% | 0.41% |
| Liquididy | 75% | 46% | 65% | 48% |